Epistem Announces Tuberculosis Diagnostic Collaboration
04-Jul-2011
- United Kingdom
The TB evaluation programme with Xcelris will continue through 2011, following which it is anticipated that it will be rolled out into a select number of remote locations prior to a full evaluation of market positioning.
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.